Cardiovascular Diseases

818 trials 341 recruiting

Filter these 818 trials by phase, country and sponsor.

Open in Search →

Extension Study of ACT-EARLY Pending

2024-513676-18-00 Transthyretin Amyloidosis 5
Comparative study of eplerenone-based treatment strategy versus irbesartan-based blood pressure lowering in obese hypertensive patients (HEB… Pending

2024-519749-31-00 Hypertension 6
MULTICENTER, DOUBLE BLIND CLINICAL TRIAL TO EVALUATE THE ANTIHEMORRAGIC EFFECT OF THE TOPICAL TRANEXAMIC ACID DURING PACEMAKER IN ANTICOAGUL… Pending

2025-520929-20-00 PACEMAKER IN ANTICOAGULATED PATIENTS 5
FIBRINOGEN REPLACEMENT TO PREVENT INTRACRANIAL HAEMORRHAGE IN ISCHEMIC STROKE PATIENTS AFTER THROMBOLYSIS: A PILOT PROBE RANDOMIZED CONTROLL… Pending

2024-516731-27-00 Ischemic stroke patients with secondary post-rtPA hypof 5
Autologous Bone Marrow derived cells for the treatment of chronic arterial Limb Ischemia in patients with high risk of amputation Pending

2025-520937-22-00 advanced chronic ischemia (fontaine III-IV class and Ru 4
PLatelet aggregation and Aspirin low response in Type One Diabetes and the association with vascular damage and diabetic Nephropathy Pending

2024-520324-29-00 Atherosclerotic cardiovascular disease 4
Short-Term Anticoagulation versus Antiplatelet Therapy for Preventing Device Thrombosis Following Left Atrial Appendage Closure. The ANDES s… Pending

2025-520954-12-00 Atrial Fibrillation Device thrombosis post-Left Atrial 6
Cognitive Function, Depression, Anxiety, and Quality of Life in Chronic Heart Failure Patients with Iron Deficiency with and without Anaemia… Pending

2024-515046-17-00 Heart Failure 6
Discontinuation or Continuation of SGLT-2 Inhibitors Before Cardiac Surgery: Impact on Postoperative Cardiovascular Outcomes Pending

2025-524395-30-00 heart failure 6
Effects of sodium-glucose cotransporter 2 inhibition on the mechanisms of heart failure with preserved ejection fraction Pending

2025-520969-51-00 Heart failure with preserved ejection fraction 6
Clinical trial of colchicine to reduce coronary artery inflammation in people with HIV. Pending

2024-520346-39-00 High cardiovascular risk in HIV patients 4
IMpAct of CardiolRxTM oVer 6 months following IL-1 Blocker cessation in pERICarditis patients – MAVERIC: A randomized, double-blind, placebo… Pending

2024-517688-21-00 Recurrent Pericarditis 5
Antibiotic Treatment Trial in Acute Coronary Syndrome Pending

2025-522136-14-00 non-ST-elevation myocardial infarction (NSTEMI), ST-ele 11
Prolonged corticosteroid therapy in scheduled cardiac surgery in intermediate/high-risk patients: a prospective multicenter randomized contr… Pending

2024-517699-39-00 high /medium risk cardiac surgery 5
Methadone for post-operative pain reduction in heart surgery Pending

2024-519224-24-00 Following heart surgery, patients experience poor posto 6
Prognostic Performance of Quantitative Myocardial Perfusion Imaging Using H2[15O] Positron Emission Tomography in Coronary Artery Disease - … Pending

2024-518706-41-01 Cardiovascular disease 5
Reassessment of statin-associated muscle symptoms in adults with familial hypercholesterolemia Pending

2025-521589-83-00 Familial hypercholesterolaemia 6
The role of meldonium and individualized physical activities in the treatment of patients with heart failure Pending

2023-509804-14-00 Chronic heart failure with preserved ejection fraction 6
Continuous versus intermittent intravenous furosemide treatment in patients hospitalised with acute heart failure Pending

2025-523589-26-00 Acute heart failure with volume overload 6
COATS (genetic Clopidogrel response testing to finetune the antithrombotic regimen in (D)OAC Treated patients undergoing PCI) Study Pending

2024-512350-17-01 Patients with coronary artery disease and an indication 6
Low-dose versus standard-dose anticoagulation with argatroban or enoxaparin during extracorporeal membrane oxygenation controlled by anti-II… Pending

2025-524553-13-00 lung and/or heart failure 4
i-Care; Quantitative-imaging in cardiac transthyretin amyloidosis Pending

2024-513310-36-01 Transthyretin amyloid cardiomyopathy 6
Strategy To Optimize PeriproCeduraL AnticOagulation in Structural Transseptal Interventions (STOP CLOT Trial) Pending

2024-516376-15-00 periprocedural anticoagulant treatment in patients trea 11
New PET/CT for (possible) cardiac sarcoidosis Pending

2025-523646-27-00 Cardiac Sarcoidosis 4